U.S. drug regulators took steps this week toward permitting sales of Eisai's Fycompa, a move for which the drug maker had pressed the DEA in an unusual lawsuit this summer.
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304069604579157920214101940.html?mod=pls_whats_news_us_business_f
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304069604579157920214101940.html?mod=pls_whats_news_us_business_f
Nessun commento:
Posta un commento